相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors
John Sarantopoulos et al.
CLINICAL CANCER RESEARCH (2016)
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study
Ronan T. Swords et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer
Lihui Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways
Khristofer Garcia et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells
G. Wei Xu et al.
PLOS ONE (2014)
Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target
Qiang Gao et al.
ONCOTARGET (2014)
Novel DNA Damage Checkpoints Mediating Cell Death Induced by the NEDD8-Activating Enzyme Inhibitor MLN4924
Jonathan L. Blank et al.
CANCER RESEARCH (2013)
Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer
Steffan T. Nawrocki et al.
CLINICAL CANCER RESEARCH (2013)
Ubiquitin E3 Ligase CRL4CDT2/DCAF2 as a Potential Chemotherapeutic Target for Ovarian Surface Epithelial Cancer
Wei-Wei Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Overcoming Platinum Resistance in Preclinical Models of Ovarian Cancer Using the Neddylation Inhibitor MLN4924
Amir A. Jazaeri et al.
MOLECULAR CANCER THERAPEUTICS (2013)
WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells
C. Mackintosh et al.
ONCOGENE (2013)
Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells
Zhongguang Luo et al.
AUTOPHAGY (2012)
Treatment-Emergent Mutations in NAEβ Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924
Michael A. Milhollen et al.
CANCER CELL (2012)
Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor
Dongping Wei et al.
CANCER RESEARCH (2012)
The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth
Zhongguang Luo et al.
CANCER RESEARCH (2012)
MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy
Steffan T. Nawrocki et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Molecular and Cellular Effects of NEDD8-Activating Enzyme Inhibition in Myeloma
Douglas W. McMillin et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Inhibition of NEDD8-conjugation pathway by novel molecules: Potential approaches to anticancer therapy
Tomoaki Tanaka et al.
MOLECULAR ONCOLOGY (2012)
The p21-Dependent Radiosensitization of Human Breast Cancer Cells by MLN4924, an Investigational Inhibitor of NEDD8 Activating Enzyme
Dong Yang et al.
PLOS ONE (2012)
Inhibition of NEDD8-Activating Enzyme Induces Rereplication and Apoptosis in Human Tumor Cells Consistent with Deregulating CDT1 Turnover
Michael A. Milhollen et al.
CANCER RESEARCH (2011)
Global Identification of Modular Cullin-RING Ligase Substrates
Michael J. Emanuele et al.
CELL (2011)
CRL4Cdt2 Master coordinator of cell cycle progression and genome stability
Tarek Abbas et al.
CELL CYCLE (2011)
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
Georgina V. Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The NEDD8-Activating Enzyme Inhibitor, MLN4924, Cooperates with TRAIL to Augment Apoptosis through Facilitating c-FLIP Degradation in Head and Neck Cancer Cells
Liqun Zhao et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Prevention of DNA re-replication in eukaryotic cells
Lan N. Truong et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2011)
Induction of p21-Dependent Senescence by an NAE Inhibitor, MLN4924, as a Mechanism of Growth Suppression
Lijun Jia et al.
NEOPLASIA (2011)
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB-dependent lymphoma
Michael A. Milhollen et al.
BLOOD (2010)
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia
Ronan T. Swords et al.
BLOOD (2010)
NEDD8-Targeting Drug MLN4924 Elicits DNA Rereplication by Stabilizing Cdt1 in S Phase, Triggering Checkpoint Activation, Apoptosis, and Senescence in Cancer Cells
Jie Jessie Lin et al.
CANCER RESEARCH (2010)
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
James E. Brownell et al.
MOLECULAR CELL (2010)
Regulation of DNA damage response pathways by the cullin-RING ubiquitin ligases
Jeffrey Hannah et al.
DNA REPAIR (2009)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes
Lorenzo Melchor et al.
BREAST CANCER RESEARCH (2009)
Targeting Proteins for Destruction by the Ubiquitin System: Implications for Human Pathobiology
Alan L. Schwartz et al.
Annual Review of Pharmacology and Toxicology (2008)
Bortezomib for the treatment of mantle cell lymphoma
Robert C. Kane et al.
CLINICAL CANCER RESEARCH (2007)
Drug discovery in the ubiquitin-proteasome system
Grzegorz Nalepa et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Oncogenic aberrations of cullin-dependent ubiquitin ligases
D Guardavaccaro et al.
ONCOGENE (2004)
Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage
J Hu et al.
NATURE CELL BIOLOGY (2004)
Cullin-based ubiquitin ligase and its control by NEDD8-conjugating system
T Chiba et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2004)
Conservation in the mechanism of nedd8 activation by the human AppBp1-Uba3 heterodimer
RN Bohnsack et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination
VN Podust et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Nedd8 modification of Cul-1 activates SCFβTrCp-dependent ubiquitination of IκBα
MA Read et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
